<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04893746</url>
  </required_header>
  <id_info>
    <org_study_id>00003</org_study_id>
    <nct_id>NCT04893746</nct_id>
  </id_info>
  <brief_title>TWK10 Improves Muscle Mass and Functional Performance in Frail Older Adults</brief_title>
  <official_title>Lactobacillus Plantarum TWK10 Improves Muscle Mass and Functional Performance in Frail Older Adults: A Randomized, Double-Blind Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan Sport University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SYNBIO TECH INC.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Taiwan Sport University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the effect of &quot;Lactobacillus plantarum TWK10 (hereinafter referred to as TWK10)&quot;&#xD;
      produced by synbiotech Biotechnology Co., Ltd. on alleviating and improving the aging and&#xD;
      debilitating diseases of the elderly. Methods: It is expected to recruit 55-85-year-old&#xD;
      senior citizens, who are assessed by the Clinical Frailty Scale (CFS) as debilitating disease&#xD;
      grades 1 to 4 as the experimental subjects of this study. All subjects were divided into&#xD;
      three groups according to the principle of balance order of frailty grades, namely (1)&#xD;
      placebo group (Placebo group, average 77.4 years old), (2) supplement TWK10 probiotic 2x1010&#xD;
      CFU/day dose group (TWK10-L) Group, average 77.1 years old), (3) supplemented with TWK10&#xD;
      probiotic 6x1010 CFU/day dose group (TWK10-H group, average 79.0 years old). The experiment&#xD;
      was supplemented for 24 consecutive weeks, and before supplementation, 6 weeks, 12 weeks, 18&#xD;
      weeks, the whole body composition and bone density test, as well as the functional fitness&#xD;
      test were carried out in sequence. The items include: 3 meters walking ( Balance and gait&#xD;
      assessment), 10-meter walking, 30-second sit-ups, and changes in the maximum grip strength of&#xD;
      the left and right hands. Results: The experimental data showed that in the functional test,&#xD;
      supplementing the TWK10-H group significantly improved the 3m gait balance, 10m walking, and&#xD;
      lower limb muscle strength (30-second sit-ups) in the functional test. In terms of body&#xD;
      composition and bone density, TWK10-H can significantly increase relative muscle mass after&#xD;
      18 weeks of supplementation. Conclusion: This study confirmed that supplementation of&#xD;
      Lactobacillus plantarum TWK10 for 18 consecutive weeks can significantly promote the&#xD;
      improvement of functional tests for the elderly, such as: 3m gait balance, 10m walking, lower&#xD;
      limb muscle strength and grip strength, and can maintain and improve muscle mass. It has the&#xD;
      effect of improving the frailty and muscle loss of the elderly.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grip strength</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use the armed grip machine (T.K.K.5401, Takei Scientific Instruments Co.,Ltd, Niigata, Japan) to measure, hold each of the left and right hands three times until they are weak, and record the maximum value</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3 meter walk</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use a pyramid, a chair, and a measuring tape to measure a distance of three meters, and ask the subject to stand up from the chair, go around the pyramid and sit down, and record the time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>30 second up to sit</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use a stopwatch to record the number of times get up from the chair in 30 seconds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>10 meter walk</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use a pyramid and a measuring tape to measure a distance of ten meters, and ask the subject to stand up from the chair, go around the pyramid and sit down, and record the time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle mass</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use dual-energy X-ray absorptiometry, DXA (Lunar iDXA, GE Healthcare, IL, USA) for no-entry measurement to determine muscle mass</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fat percentage</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use dual-energy X-ray absorptiometry, DXA (Lunar iDXA, GE Healthcare, IL, USA) for no-entry measurement to determine fat percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bone mineral density test</measure>
    <time_frame>every 6 weeks</time_frame>
    <description>Use dual-energy X-ray absorptiometry, DXA (Lunar iDXA, GE Healthcare, IL, USA) for no-entry measurement to determine bone mineral density</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Frail Elderly Syndrome</condition>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TWK10-L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TWK10-H</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus plantarum TWK10-L</intervention_name>
    <description>Low dose: 2x1010 CFU/day</description>
    <arm_group_label>TWK10-L</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Maltodextrin</intervention_name>
    <description>0x1010 CFU/day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus plantarum TWK10-H</intervention_name>
    <description>High dose: 6x1010 CFU/day</description>
    <arm_group_label>TWK10-H</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The clinical frailty scale (Clinical Frailty Scale, CFS) assessed as frailty grade&#xD;
             1~4.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosed by the attending physician and confirmed that there is no stroke,&#xD;
             hypertension patients and no exercise contraindications&#xD;
&#xD;
          -  Can't sit to stand independently&#xD;
&#xD;
          -  long-term antibiotics.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chi-Chang Huang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>PI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan Sport University</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 14, 2021</study_first_submitted>
  <study_first_submitted_qc>May 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Taiwan Sport University</investigator_affiliation>
    <investigator_full_name>Chi-Chang Huang</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

